Granulosa cell insight: unraveling the potential of menstrual blood-derived stem cells and their exosomes on mitochondrial mechanisms in polycystic ovary syndrome (PCOS)
Open Access
- 17 August 2024
- journal article
- research article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 17 (1) , 1-15
Abstract
Background: Polycystic ovary syndrome (PCOS) presents a significant challenge in women’s reproductive health, characterized by disrupted folliculogenesis and ovulatory dysfunction. Central to PCOS pathogenesis are granulosa cells, whose dysfunction contributes to aberrant steroid hormone production and oxidative stress. Mitochondrial dysfunction emerges as a key player, influencing cellular energetics, oxidative stress, and steroidogenesis. This study investigates the therapeutic potential of menstrual blood-derived stem cells (MenSCs) and their exosomes in mitigating mitochondrial dysfunction and oxidative stress in PCOS granulosa cells. Methods: Using a rat model of PCOS induced by letrozole, granulosa cells were harvested and cultured. MenSCs and their exosomes were employed to assess their effects on mitochondrial biogenesis, oxidative stress, and estrogen production in PCOS granulosa cells. Results: Results showed diminished mitochondrial biogenesis and increased oxidative stress in PCOS granulosa cells, alongside reduced estrogen production. Treatment with MenSCs and their exosomes demonstrated significant improvements in mitochondrial biogenesis, oxidative stress levels, and estrogen production in PCOS granulosa cells. Further analysis showed MenSCs' superior efficacy over exosomes, attributed to their sustained secretion of bioactive factors. Mechanistically, MenSCs and exosomes activated pathways related to mitochondrial biogenesis and antioxidative defense, highlighting their therapeutic potential for PCOS. Conclusions: This study offers insights into granulosa cells mitochondria’s role in PCOS pathogenesis and proposes MenSCs and exosomes as a potential strategy for mitigating mitochondrial dysfunction and oxidative stress in PCOS. Further research is needed to understand underlying mechanisms and validate clinical efficacy, presenting promising avenues for addressing PCOS complexity.Keywords
This publication has 66 references indexed in Scilit:
- Sustainable Production and Activity Determination of Serum-Free Conditioned Medium from Menstrual Blood-Derived Endometrial Stem CellsApplied Biochemistry and Biotechnology, 2022
- Placental mesenchymal stem cells restore glucose and energy homeostasis in obesogenic adipocytesCell and tissue research, 2022
- A simple method for quantitating confocal fluorescent imagesBiochemistry and Biophysics Reports, 2021
- Vitamin D3 affects mitochondrial biogenesis through mitogen‐activated protein kinase in polycystic ovary syndrome mouse modelJournal of Cellular Physiology, 2020
- PGC-1α protects against oxidized low-density lipoprotein and luteinizing hormone-induced granulosa cells injury through ROS-p38 pathwayHuman Cell, 2019
- The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicineCytokine & Growth Factor Reviews, 2019
- The effects of human menstrual blood stem cells‐derived granulosa cells on ovarian follicle formation in a rat model of premature ovarian failureMicroscopy Research and Technique, 2018
- Advances in PCOS Pathogenesis and Progression—Mitochondrial Mutations and Dysfunction2018
- Oxidative stress in granulosa cells contributes to poor oocyte quality and IVF-ET outcomes in women with polycystic ovary syndromeFrontiers of Medicine, 2017
- PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cellsCardiovascular Research, 2005